Physical exercise program to improve aerobic capacity in people with cardiovascular disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational record-based project uses clinical data from patients seen at Clínica el Rosario between 2015 and 2024 who completed a baseline exercise stress test and a post-intervention stress test after 20 supervised sessions. Eligible records must show attendance of at least 90% of prescribed sessions and complete data for the measured outcomes. The primary outcome is change in aerobic capacity measured by exercise stress testing before and after the rehabilitation program. Analysis will compare pre- and post-intervention aerobic capacity in this real-world clinical cohort to characterize program effectiveness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Records between 2015 and 2024
* Men and women, between 35 and 90 years old.
* Clinical diagnosis of cardiovascular disease.
* Must be patient from Clínica el Rosario.
* Participants must have completed a baseline exercise stress test and a post-intervention stress test after the 20 sessions, and must have attended at least 90% of the prescribed sessions

Exclusion Criteria:

* Records containing incomplete data

Where it's running

• Fundación universitaria María Cano
  Medellín, Colombia Recruiting

Study contacts

• Study coordinator: Catalina Lopera, Msc in cancer
• Email: catalinalopera8@gmail.com
• Phone: +573206728934

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.